» Articles » PMID: 39773724

Hypercalcemia and Co-occurring TBX1 Mutation in Glycogen Storage Disease Type Ib: Case Report

Overview
Publisher Biomed Central
Specialty Genetics
Date 2025 Jan 8
PMID 39773724
Authors
Affiliations
Soon will be listed here.
Abstract

Glycogen Storage Disease Type Ib (GSD-Ib) is a rare autosomal recessive metabolic disorder caused by mutations in SLC37A4, leading to a deficiency in glucose-6-phosphate translocase. This disorder is characterized by impaired glycogenolysis and gluconeogenesis, resulting in clinical and metabolic manifestations. We report a three-month-old Moroccan female patient presenting with doll-like facies, hepatomegaly, dysmorphic features, and developmental delays. Laboratory analysis revealed hypoglycemia, elevated triglyceride levels, hypercalcemia, and neutropenia. Genetic testing confirmed a homozygous pathogenic variant in SLC37A4 and a heterozygous variant of uncertain significance in TBX1. Initial management included a lactose-free and galactose-free diet, multivitamin supplementation, and granulocyte colony-stimulating factor (G-CSF) therapy to address neutropenia. A novel aspect of this case involves hypercalcemia as an unusual finding in GSD-Ib and the co-occurrence of a variant in the TBX1 gene, which is not typically associated with the disease but may contribute to the patient's clinical presentation. These findings add a new dimension to our understanding of GSD-Ib and suggest potential avenues for future research to elucidate these genetic interactions and their impact on clinical outcomes.

References
1.
Rentzsch P, Witten D, Cooper G, Shendure J, Kircher M . CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2018; 47(D1):D886-D894. PMC: 6323892. DOI: 10.1093/nar/gky1016. View

2.
Sachmechi I, Shah G, Rezainadimi L, Blaustein D, Rosner F . Misleading acute hypercalcemia due to hyperlipidemia: a method-dependent error. Endocr Pract. 2004; 3(5):293-6. DOI: 10.4158/EP.3.5.293. View

3.
Hiraiwa H, Pan C, Lin B, Moses S, Chou J . Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b. J Biol Chem. 1999; 274(9):5532-6. DOI: 10.1074/jbc.274.9.5532. View

4.
Sim S, Jang Y, Park T, Park B, Lee Y, Jun H . Molecular mechanisms of aberrant neutrophil differentiation in glycogen storage disease type Ib. Cell Mol Life Sci. 2022; 79(5):246. PMC: 11071875. DOI: 10.1007/s00018-022-04267-5. View

5.
Ebrahimi Meimand S, Azizi G, Yazdani R, Sanadgol N, Rezaei N . Novel mutation of SLC37A4 in a glycogen storage disease type Ib patient with neutropenia, horseshoe kidney, and arteriovenous malformation: a case report. Immunol Res. 2022; 71(1):107-111. DOI: 10.1007/s12026-022-09320-w. View